A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Ongoing studies after the drug has been made available on the market. These involve the safety surveillance and technical support of the drug, and can evaluate the drug in previously unknown cases, eg in interactions with other drugs and with pregnant women who are usually not found in any of the other phases in drug trials.
See also:
Phase I trials
Phase II trials
Phase III trials
Clinical trial
Clinical trial enrolment
Pre-clinical trials
Line extension, Committee for Medicinal Products for Human Use (CHMP), Reimbursement, Expanded access, International Clinical Trial Registry Platform (ICTRP), Blind (clinical trial terms), Institutional review board (IRB) - pharmacoeconomics, Diagnostic trials, Double-blind trial, Trial endpoint, Loss leader, Umbrella pricing, Return on sales enablement (ROSE), Prophylaxis, Cohort,
No results were found
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...